Stand Up To Cancer-supported Clinical Trials Seeking To Extend CAR T-cell Therapy to Solid Tumors, Reported at AACR Annual Meeting

ATLANTA, March 31, 2019 /PRNewswire/ -- Stand Up To Cancer (SU2C) is helping scientists make progress in one of the most important areas of cancer research today: expanding the use of autologous CAR T-cell immunotherapy beyond leukemia and other blood cancers to solid tumors such as...

from PR Newswire: https://ift.tt/2YFGegX